Behavioral Health Initial Intake Outreach

NCT07790107 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6200

Last updated 2026-08-31

No results posted yet for this study

Summary

The goal of this study is to help patients get seen sooner for behavioral health appointments by informing them about group therapy options, which allow more patients to be seen at once, often more quickly than 1:1 therapy. We will test whether messages describing the benefits of group therapy might encourage more patients to sign up for group therapy, thereby shortening patients' time to beginning therapy.

Conditions

  • Behavioral Health

Interventions

BEHAVIORAL

Pre-intake appointment informational messages

Informational messages delivered through MyChart or text message before a scheduled behavioral health intake call. The MyChart messages explain that the intake call is a one-time appointment to determine the most appropriate treatment plan, describe potential benefits of group psychotherapy, and provide a link to additional educational information about group therapy. Patient instructions with the same information added to the appointment within MyChart. Patients who do not have MyChart but can be sent text messages will get brief text messages with a link to MyChart to view patient instructions with information about group therapy.

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Gail Rosenbaum, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07790107 on ClinicalTrials.gov